Internal Medicine, Hematology & Oncology · Bayonne, NJ
NPI
1689620700
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
27 E 29th St
Bayonne, NJ, 07002
Phone (201) 858-1211
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
85,904 services
Medicare patients, 2024
298
Average age 76
Drug cost, 2024
$1.2M
955 prescriptions
Company payments, 2025
$1,027
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Devarajan P Iyengar was code J1756 (injection, iron sucrose, 1 mg), 31,800 times for 42 patients. In total Devarajan P Iyengar billed 85,904 services in 109 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 31,800 | 42 | $0.18 | $5,617 |
| J0897 Injection, denosumab, 1 mg | Office | 6,375 | 25 | $20.53 | $131K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 5,004 | 45 | $0.07 | $367 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,324 | 33 | $0.09 | $210 |
| 85025 Blood Count | Office | 1,906 | 258 | $7.61 | $15K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,893 | 33 | $0.23 | $433 |
| 36415 Venipuncture Blood Collection | Office | 1,578 | 253 | $7.35 | $12K |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 1,481 | 13 | $5.75 | $8,513 |
| 96361 Intravenous Infusion, Hydration | Office | 1,167 | 78 | $11.62 | $14K |
| 99214 Office E&M - Established | Office | 1,126 | 237 | $113.94 | $128K |
| 99213 Office E&M - Established | Office | 927 | 179 | $84.16 | $78K |
| 96367 Intravenous Infusion, Hydration | Office | 672 | 70 | $26.87 | $18K |
| J3490 Unclassified drugs | Office | 644 | 76 | $0.55 | $355 |
| 96415 Chemotherapy Administration | Office | 587 | 30 | $26.75 | $16K |
| 99233 Hospital E&M - Subsequent | Facility | 434 | 62 | $108.07 | $47K |
By year: 2022 $2.0M for 116,842 services; 2023 $2.0M for 118,136 services; 2024 $1.4M for 85,904 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,906 | 258 | $7.61 | $15K |
| 36415 Venipuncture Blood Collection | 1,578 | 253 | $7.35 | $12K |
Medicare prescription drug claims, 2024
In 2024, the drug Devarajan P Iyengar prescribed most often to Medicare patients was Montelukast Sodium, with 39 prescriptions and refills. In total Devarajan P Iyengar wrote 955 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 39 | 48 | Under 11 | $356 |
| Xgeva Denosumab | 25 | 25 | Under 11 | $77K |
| Retacrit Epoetin Alfa-Epbx | 24 | 24 | Under 11 | $8,842 |
| Pantoprazole Sodium Generic | 21 | 25 | Under 11 | $210 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 21 | 21 | Under 11 | $261K |
| Fosaprepitant Dimeglumine Generic | 20 | 20 | Under 11 | $982 |
| Ondansetron Odt Ondansetron | 20 | 20 | 11 | $203 |
| Famotidine Generic | 19 | 19 | Under 11 | $42.43 |
| Clopidogrel Clopidogrel Bisulfate | 18 | 25 | Under 11 | $183 |
| Hydromorphone Hcl Generic | 17 | 17 | Under 11 | $281 |
| Atorvastatin Calcium Generic | 17 | 19 | Under 11 | $122 |
| Alprazolam Generic | 17 | 19 | Under 11 | $53.97 |
| Olanzapine Generic | 17 | 17 | Under 11 | $132 |
| Hydrocortisone Generic | 16 | 22 | Under 11 | $253 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 15 | 15 | Under 11 | $243 |
Brand drugs: - claims; generic drugs: 682 claims; opioid claims: 68.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Devarajan P Iyengar $1,027 ($1,027 in general payments such as food, travel and fees) from 22 companies. The largest payer was Janssen Biotech, Inc. with $276.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 11 | $276 |
| Exelixis Inc. EXEL | 1 | $99 |
| Abbvie Inc. ABBV | 4 | $68.23 |
| GlaxoSmithKline, LLC. GSK | 3 | $62.72 |
| Merck Sharp & Dohme LLC MRK | 3 | $55.51 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $55.01 |
| Lilly USA, LLC LLY | 3 | $50.99 |
| Janssen Pharmaceuticals, Inc JNJ | 4 | $48.28 |
| Pfizer Inc. PFE | 2 | $36.75 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $33.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.